Jasper Therapeutics, Inc.

Jasper Therapeutics, Inc. completed its business combination with Amplitude Healthcare Acquisition Corporation, the Nasdaq-listed SPAC that traded under the ticker AMHC and was sponsored by Amplitude Healthcare Sponsor LLC. The blank-check company raised its IPO in 2021, targeting opportunities in the healthcare and biopharmaceutical sector. The de-SPAC transaction brought Jasper Therapeutics—a clinical-stage biopharmaceutical company developing antibody-based conditioning agents designed to enable safer hematopoietic stem cell transplantation—into the public markets. The June 2023 Form 8-K filing reflects the combined company's ongoing post-merger reporting obligations as a publicly traded entity. For full deal timelines, sponsor details, and filing history on Jasper Therapeutics and hundreds of other SPAC transactions, sign up for complete data access at SpacDesk.